We report the outcome at ten to 15 years of two-stage revision for hip infection in 99 patients using the Prostalac articulated hip spacer system. All the patients were contacted to determine their current functional and infection status using the Oxford-12, Short form-12, and Western Ontario and McMaster University Osteoarthritis Index questionnaires. A total of 11 of the 99 patients had a further infection, of whom seven responded to repeat surgery with no further sequelae. The mean interval between the stages was five months (1 to 36). We were able to review 48 living patients, with a mean age of 72 years (46 to 86), 34 (71%) of whom provided health-related quality-of-life outcome scores. The mean follow-up was 12 years (10 to 15). The long-term success rate was 89% and with additional surgery this rose to 96%. The mean global Western Ontario and McMaster University Osteoarthritis Index score was 80.6 ( Two-stage revision for hip infection using a Prostalac interim spacer offers a predictable and lasting solution for patients with this difficult problem.
determine predictors of pain, function and activity level 1–2 years after revision hip arthroplasty and define quality of life outcomes after revision total hip replacement.
When considering WOMAC pain as an outcome variable, factors predictive of improving category outcome included baseline WOMAC function (p= 0.001), age between 60–70 (p<
0.004), male gender (p= 0.005), lower Charnley class (p<
0.001) and no previous revisions (p <
0.023). Baseline WOMAC pain did not predict final pain outcome. Baseline WOMAC function (p=0.001), the indication for the operation (p=0.007), and the operating surgeon were significant predictors of UCLA activity at follow up. Peri or post-operative complications were not an adverse predictor of physical function, pain or activity.
A prospective cohort of 222 patients who underwent revision hip replacement between April 2001 and March 2004 was evaluated to determine predictors of function, pain and activity level between one and two years post-operatively, and to define quality of life outcomes using validated patient reported outcome tools. Predictive models were developed and proportional odds regression analyses were performed to identify factors that predict quality of life outcomes at one and two years post-operatively. The dependent outcome variables were the Western Ontario and McMaster Osteoarthritis Index (WOMAC) function and pain scores, and University of California Los Angeles activity scores. The independent variables included patient demographics, operative factors, and objective quality of life parameters, including pre-operative WOMAC, and the Short Form-12 mental component score. There was a significant improvement ( Predictors of quality of life outcomes after revision hip replacement were established. Although some patient-specific and surgery-specific variables were important, age, gender, Charnley class and pre-operative WOMAC function score had the most robust associations with outcome.
We reviewed prospectively, after skeletal maturity, a series of 24 patients (25 hips) with severe acute-on-chronic slipped capital femoral epiphysis which had been treated by subcapital cuneiform osteotomy. Patients were followed up for a mean of 8 years, 3 months (2 years, 5 months to 16 years, 4 months). Bedrest with ‘slings and springs’ had been used for a mean of 22 days (19 to 35) in 22 patients, and bedrest alone in two, before definitive surgery. The Iowa hip score, the Harris hip score and Boyer’s radiological classification for degenerative disease were used. The mean Iowa hip score at follow-up was 93.7 (69 to 100) and the mean Harris hip score 95.6 (78 to 100). Degenerative joint changes were graded as 0 in 19 hips, grade 1 in four and grade 2 in two. The rate of avascular necrosis was 12% (3 of 25) and the rate of chondrolysis was 16% (4 of 25). We conclude that after a period of bed rest with slings and springs for three weeks to gain stability, subcapital cuneiform osteotomy for severe acute-on-chronic slipped capital femoral epiphysis is a satisfactory method of treatment with an acceptable rate of complication.
The clinical results of carbon matrix support prostheses for treatment of articular cartilage defects of the femoral condyle and patella were assessed in 97 patients (100 prostheses) between 1989–99. Patients were independently reviewed by subjective and objective criteria. Pre-operative and current visual analogue scores for pain (VAPS); Stanmore and modified Cincinnati functional rating scores were obtained. Forty-nine patients had lesions of the patella, forty-four patients of the medial femoral condyle and seven patients of the lateral femoral condyle. Patella group – subjectively 49% reported they were improved, 8% unchanged and 43% worse. Stanmore score: 6 excellent and 17 good (47%), 5 fair and 21 were poor. The Cincinnati score increased from 26. 5 pre-operatively to 47. 5 currently (p<
0. 001). The mean VAPS decreased from 8. 1 to 5. 0 (p<
0. 001). Medial femoral condyle group – subjectively 60% reported they were improved, 14% unchanged and 26% worse. Stanmore score: 8 excellent and 16 good (55%), 8 fair and 12 poor. The Cincinnati score increased from 22. 3 pre-operatively to 48. 5 currently (p<
0. 001). The mean VAPS decreased from 8. 6 to 5. 1 (p<
0. 001). Lateral femoral condyle group – subjectively 42% reported they were improved, 29% unchanged and 29% worse. Stanmore score: 2 excellent and 1 good (43%), 2 fair and 2 poor. The Cincinnati score increased from 35. 0 pre-operatively to 52. 0 currently (p<
0. 25). The mean VAPS decreased from 6. 5 to 4. 0 (p<
0. 25). There were no statistical differences in outcome based upon gender, site, pre-operative functional rating score, diagnosis, or any correlation with age or length of follow up, or when comparing excellent/good with fair/ poor subgroups in patellae or femoral condyles in relation to these variables. This study demonstrated that 49% improved in the patella group, 60% in the medial femoral condyle and 43% in the lateral femoral condyle groups. The use of these prostheses was effective on the medial femoral condyle for periods up to 10 years but the use in the patella and lateral femoral condyle was less successful.